Loading...
Remembering that e-cigarette, or vaping, product use–associated lung injury (EVALI) was a rising concern through 2019 is difficult. Although understanding of the syndrome has improved, the exact causative agents and mechanism of injury remain unclear.
Investigators reviewed records of 2558 U.S. patients hospitalized with EVALI and reported to the U.S. Centers for Disease Control through January 7, 2020; about two thirds of patients were men. Sixty patients (2.3%) died. Non-Hispanic whites accounted for nearly 80% of patients but only 60% of deaths. Patients with fatal disease were older than those with nonfatal disease (median ages, 51 vs. 24) and were more likely to have underlying respiratory, cardiac, or psychiatric disease and were less …